Novo Nordisk plans €2B site expansion

The latest stories trending on MedCity News.

Editor's Pick

Top Story Novo Nordisk Plans €2B Site Expansion as GLP-1 Drug Demand Grows Novo Nordisk's planned expansion will more than double the footprint of its France production site, bringing new capacity for manufacturing GLP-1 drugs for metabolic conditions. The location is already one of the company's largest for making diabetes products. Sponsored Content HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI Presented by MedCity News & HealthBook+ HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees. Learn More. Black Friday, Cyber Monday Savings Continue For You While the retail sales are over, you can still save $700 on your seat for INVEST 2024 taking place May 21-22 in Chicago at the Ritz. Don't miss out on these great savings and your opportunity to network with the best in healthcare and stay abreast of the latest industry trends and conversations. Hurry these savings only last until Dec 15th. Get My Savings Now

Featured News

Nuance, Paige Launch Network to Speed Up Second Opinions in Pathology At RSNA 2023, healthcare AI startup Paige announced a partnership with Nuance to launch what the companies say is "the largest digital consultation network in pathology." Paige's digital pathology tools will be embedded into PowerShare, Nuance's nationwide image sharing network with the goal of connecting more pathology labs to expert second opinions. Report: 83% of MA Beneficiaries Choose $0 Premium Plans for 2024 Seniors are mostly still interested in $0 premium Medicare Advantage plans, according to a new eHealth report. However, slightly fewer seniors are choosing these plans compared to previous years. What 2 Investors Are Looking for from Mental Health Startups One investor is most interested in mental health startups that focus on high acuity care, while another wants to see companies that are built with the end-user in mind, they shared during recent interviews. GSK Drug Pulled From Market Beats J&J Multiple Myeloma Med in Phase 3 Test GSK took Blenrep off the market last year after the multiple myeloma drug failed its confirmatory study. But GSK now says it has interim data showing Blenrep beat a blockbuster Johnson & Johnson drug in a head-to-head Phase 3 study testing it as an earlier line of therapy. Breaking Down Barriers for Payer Adoption of Virtual Care Providers As we navigate the complex terrain of virtual care integration, it is imperative to recognize the significance of payers as catalysts for change. By addressing the technological, procedural, and regulatory roadblocks head-on, payers can position themselves as champions of innovation and value

Resources

MedCity Pivot Podcast: Health Equity in Opioid Addiction Treatment With Dr. Brian Clear Dr. Brian Clear, an addiction treatment physician and chief medical officer of Bicycle Health, believes that telemedicine is one way to improve access and reduce the inequities inherence in addiction treatment. The other is education. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe